Skip to content
My WebMD Sign In, Sign Up
Prostate cancer vaccination approval by FDA
avatar
billmilner posted:
I heard on the tv news tonight the FDA has appeoved a vaccination to as a treatment for prostate cancer that is not responding to other treatment such as hormonal therapy. Any more detailed information available???
Reply
 
avatar
Gottano responded:
http://www.npr.org/templates/story/story.php?storyId=126390555

http://www.dailyfinance.com/story/company-news/dendreons-prostate-cancer-vaccine-approved-shares-soar-before/19459084/

2nd article cites study results as 4.1 month overall survival extension over placebo in 512 patients with metastatic hormone refractory PCa. Also notes serious adverse reactions in approx. one quarter of patients receiving Provenge and $93,000 treatment cost.
 
avatar
Caprice_WebMD_Staff responded:
For more on this, read WebMD's article:

FDA OKs Provenge for Prostate Cancer Therapy

Here's an excerpt:

"Provenge doesn't cure prostate cancer or prevent it from getting worse over time. But it does extend survival -- by months for most patients, by years for some.Provenge isn't your everyday vaccine. It's an immune therapy created by harvesting immune cells from a patient, genetically engineering them to fight prostate cancer, and then infusing them back into the patient.


"It's approved only for treatment of asymptomatic or minimally symptomatic patients with prostate cancer that has spread outside the prostate and no longer responds to hormone therapy."


Helpful Tips

How to get the most out of your prostate cancer consultationExpert
Here are a few tips to get the most out of your prostate cancer surgical or radiation oncology consultation: 1. Have extra copies of all ... More
Was this Helpful?
4 of 4 found this helpful

Related News

There was an error with this newsfeed

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

For more information, visit the Duke Health Prostate Cancer Center